STERIS plc Earnings Per Share Disclosure
| Years ended March 31, | 2025 | 2024 | 2023 | |||||||||||||||||
Denominator (shares in thousands): | ||||||||||||||||||||
| Weighted average shares outstanding—basic | 98,575 | 98,787 | 99,706 | |||||||||||||||||
| Dilutive effect of share equivalents | 494 | 572 | 540 | |||||||||||||||||
| Weighted average shares outstanding and share equivalents—diluted | 99,069 | 99,359 | 100,246 | |||||||||||||||||
| Years ended March 31, | 2025 | 2024 | 2023 | |||||||||||||||||
Number of ordinary share options (shares in thousands) | 671 | 606 | 578 | |||||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | May 29, 2025 | Showing above |
| 2024 | May 29, 2024 | |
| 2023 | May 26, 2023 | |
| 2022 | May 31, 2022 | |
| 2021 | May 28, 2021 | |
| 2020 | May 29, 2020 | |
| 2019 | May 30, 2019 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.